(1 - 11 von 14
)
Neuer Covid-19-Schnelltest in Entwicklung - MT-Portalmt-portal.de
mt-portal.de
Ein großes Manko von Antigen-Schnelltests, das hat zuletzt die Studie einer Forschungsgruppe um Heinrich Scheiblauer vom deutschen Paul-Ehrlich-Institut ... Ein großes Manko von Antigen-Schnelltests, das hat zuletzt die Studie einer Forschungsgruppe um Heinrich Scheiblauer vom deutschen Paul-Ehrlich-Institut ...
COVID-19: How is Severity of the Disease Related to Antibody …
www.bionity.com
WebNov 6, · Professor Barbara Schnierle, head of Section "AIDS, New and Novel Pathogens", and her teams, and Dr Heinrich Scheiblauer, deputy head of the Testing Laboratory for In-vitro Diagnostic Medical Devices jointly with researchers of the University Hospital at Frankfurt/Main and the Leibniz-Institut for Primate Research at Göttingen, …
Press Releases - Antibodies Post-SARS-CoV-2 Infection – New …
www.pei.de
WebJan 21, · The in vitro diagnostics (IVD) Testing Laboratory at the Paul-Ehrlich-Institut, headed by Dr Heinrich Scheiblauer, in cooperation with the University Hospital Frankfurt am Main, measured antibody responses over a period of more than 430 days after SARS-CoV-2 infection samples from 390 patients with different degrees of COVID-19 …
Press Releases - COVID-19: How is Severity of the Disease Related …
www.pei.de
WebProfessor Barbara Schnierle, head of Section "AIDS, New and Novel Pathogens", and her teams, and Dr Heinrich Scheiblauer, deputy head of the Testing Laboratory for In-vitro Diagnostic Medical Devices jointly with researchers of the University Hospital at Frankfurt/Main and the Leibniz-Institute for Primate Research at Göttingen, characterised ...
sortiert nach Relevanz / Datum